Preparing your experience, please wait…
K
Guidelines & protocols
TIRZEPATIDE FOR MANAGING OVERWEIGHT AND OBESITY
National Institute for Health and Care Excellence (NICE)
PDF202454 pages303 KB
The guidance outlines the evidence considered by the National Institute for Health and Care Excellence (NICE) regarding tirzepatide's effectiveness in managing overweight and obesity. It emphasizes the importance of integrating individual patient needs and preferences into treatment decisions. The document also discusses the responsibilities of healthcare professionals and commissioners in applying the recommendations and ensuring equitable access to treatment.
No account needed
Discuss clinical evidence & guidelines
Examine in Ask OslerAsk this resource
Answers from this document onlyMore like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Uganda Diabetes Management Guidelines – Summarised (2026)
Same clinical topic · Endocrinology
Kiruddu DKA guidelines
Same clinical topic · Endocrinology
Management of DKA
Same clinical topic · Endocrinology
Pharmacotherapy for Obesity Management: 2025 Guidelines
Same clinical topic · Endocrinology
ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology
Standards of Care in Diabetes 2026
Same clinical topic · Endocrinology
RETINOPATHY, NEUROPATHY, AND FOOT CARE: STANDARDS OF CARE IN DIABETES—2026
Same clinical topic · Endocrinology
6. GLYCEMIC GOALS, HYPOGLYCEMIA, AND HYPERGLYCEMIC CRISES: STANDARDS OF CARE IN DIABETES—2026
Same clinical topic · Endocrinology
2026 ETA GUIDELINE ON INTERFERENCE IN IMMUNOASSAY MEASUREMENTS USED IN ASSESSMENT OF THYROID FUNCTION
Same clinical topic · Endocrinology